Concerns are often expressed by individuals and health care providers who aren’t up to date with current health practices regarding BHRT. One of the biggest concerns with most people and health care providers is that it may cause or increase the potential for cancer, particularly breast or uterine. Studies have shown that females on estradiol balanced with progesterone actually have a reduced incidence of breast cancer compared to the general public. (reference study here). In addition, the current literature shows that BHRT is safe and is NOT associated with an increased risk of cancer or mortality. (cite study)  Many health care providers have not spent the time to become educated on the up-to-date practices and literature regard BHRT and often refer to studies referencing forms of estrogens that are not the natural hormone estradiol that your body makes and used in our replacement therapy. This also applies to frequently referencing progestin instead of progesterone. There is a proverbial fear and misunderstanding regarding hormone replacement and many still rely on the WHI study from 20 years ago that has proven to be flawed. Out of fear of “risks” and not being well informed of the current, up to date literature and practices, many providers would just rather advise their patient not to do hormone replacement therapy. This is a grave disservice to the patient as proper bioidentical hormone replacement extends health span and life expectancy for both men and women. It is imperative that all health care providers be up to date on clinical therapies if they are going to advise a client on that therapy. 

Providers at Executive Medicine have advanced training in bioidentical hormone replacement therapy. 

We invite you to a consultation to see if it is suitable for you.